FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2005282952> ?p ?o ?g. }

• W2005282952 endingPage "403" @default.
• W2005282952 startingPage "400" @default.
• W2005282952 abstract "Imatinib combined with high-dose chemotherapy is now becoming the gold standard for treatment of Philadelphia chromosome-positive acute leukemias. However, in all studies imatinib dosage was tapered to 400–600 mg per day. We decided to initiate a clinical trial to evaluate an opposite strategy based on high-dose imatinib (800 mg per day) combined with a less intensive chemotherapeutic regimen (vincristine and dexamethasone), which we called the DIV induction regimen. Thirty-one patients (18 relapsing or refractory Ph+ acute lymphoblastic leukemias and 13 lymphoid blast crisis chronic myelogenous leukemias) were enrolled. Complete remission (CR) was obtained in 28 out of 30 assessable patients. The median bcr-abl/abl ratio after the induction course was 0.1%. Median time to neutrophil recovery was 21 days. Fungus infections were observed in six patients out of 31 and possibly related to dexamethasone. Neuropathy due to vincristine was noted in 14 cases. Nine out of 19 patients under 55 years received allogenic stem cell transplantation after a median time of 78 days post-CR. Patients older than 55 years experienced a 90% CR rate without additional toxicities, suggesting the DIV regimen may also be proposed as a front line therapy in older patients." @default.
• W2005282952 created "2016-06-24" @default.
• W2005282952 creator A5000436961 @default.
• W2005282952 creator A5003572390 @default.
• W2005282952 creator A5004066423 @default.
• W2005282952 creator A5007550143 @default.
• W2005282952 creator A5010990164 @default.
• W2005282952 creator A5011668592 @default.
• W2005282952 creator A5023008376 @default.
• W2005282952 creator A5025925500 @default.
• W2005282952 creator A5030974449 @default.
• W2005282952 creator A5049141358 @default.
• W2005282952 creator A5052564121 @default.
• W2005282952 creator A5055178731 @default.
• W2005282952 creator A5055797334 @default.
• W2005282952 creator A5064103067 @default.
• W2005282952 creator A5068342352 @default.
• W2005282952 creator A5070855192 @default.
• W2005282952 creator A5072721892 @default.
• W2005282952 creator A5077081397 @default.
• W2005282952 date "2006-01-26" @default.
• W2005282952 modified "2023-10-12" @default.
• W2005282952 title "High-dose imatinib mesylate combined with vincristine and dexamethasone (DIV regimen) as induction therapy in patients with resistant Philadelphia-positive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myeloid leukemia" @default.
• W2005282952 cites W1965295262 @default.
• W2005282952 cites W1965956395 @default.
• W2005282952 cites W1999614615 @default.
• W2005282952 cites W2036862498 @default.
• W2005282952 cites W2076736727 @default.
• W2005282952 cites W2079446921 @default.
• W2005282952 cites W2088964348 @default.
• W2005282952 cites W2105098746 @default.
• W2005282952 cites W2108008366 @default.
• W2005282952 cites W2120033838 @default.
• W2005282952 cites W2131067167 @default.
• W2005282952 cites W2139499066 @default.
• W2005282952 cites W2153701773 @default.
• W2005282952 cites W2167829945 @default.
• W2005282952 cites W2171722798 @default.
• W2005282952 cites W2312804644 @default.
• W2005282952 doi "https://doi.org/10.1038/sj.leu.2404115" @default.
• W2005282952 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16437142" @default.
• W2005282952 hasPublicationYear "2006" @default.
• W2005282952 type Work @default.
• W2005282952 sameAs 2005282952 @default.
• W2005282952 citedByCount "67" @default.
• W2005282952 countsByYear W20052829522012 @default.
• W2005282952 countsByYear W20052829522013 @default.
• W2005282952 countsByYear W20052829522014 @default.
• W2005282952 countsByYear W20052829522015 @default.
• W2005282952 countsByYear W20052829522016 @default.
• W2005282952 countsByYear W20052829522017 @default.
• W2005282952 countsByYear W20052829522018 @default.
• W2005282952 countsByYear W20052829522019 @default.
• W2005282952 countsByYear W20052829522020 @default.
• W2005282952 countsByYear W20052829522021 @default.
• W2005282952 countsByYear W20052829522022 @default.
• W2005282952 countsByYear W20052829522023 @default.
• W2005282952 crossrefType "journal-article" @default.
• W2005282952 hasAuthorship W2005282952A5000436961 @default.
• W2005282952 hasAuthorship W2005282952A5003572390 @default.
• W2005282952 hasAuthorship W2005282952A5004066423 @default.
• W2005282952 hasAuthorship W2005282952A5007550143 @default.
• W2005282952 hasAuthorship W2005282952A5010990164 @default.
• W2005282952 hasAuthorship W2005282952A5011668592 @default.
• W2005282952 hasAuthorship W2005282952A5023008376 @default.
• W2005282952 hasAuthorship W2005282952A5025925500 @default.
• W2005282952 hasAuthorship W2005282952A5030974449 @default.
• W2005282952 hasAuthorship W2005282952A5049141358 @default.
• W2005282952 hasAuthorship W2005282952A5052564121 @default.
• W2005282952 hasAuthorship W2005282952A5055178731 @default.
• W2005282952 hasAuthorship W2005282952A5055797334 @default.
• W2005282952 hasAuthorship W2005282952A5064103067 @default.
• W2005282952 hasAuthorship W2005282952A5068342352 @default.
• W2005282952 hasAuthorship W2005282952A5070855192 @default.
• W2005282952 hasAuthorship W2005282952A5072721892 @default.
• W2005282952 hasAuthorship W2005282952A5077081397 @default.
• W2005282952 hasBestOaLocation W20052829521 @default.
• W2005282952 hasConcept C104317684 @default.
• W2005282952 hasConcept C126322002 @default.
• W2005282952 hasConcept C138626823 @default.
• W2005282952 hasConcept C141071460 @default.
• W2005282952 hasConcept C203014093 @default.
• W2005282952 hasConcept C2776694085 @default.
• W2005282952 hasConcept C2776755627 @default.
• W2005282952 hasConcept C2776960273 @default.
• W2005282952 hasConcept C2777583451 @default.
• W2005282952 hasConcept C2778461978 @default.
• W2005282952 hasConcept C2778729363 @default.
• W2005282952 hasConcept C2778904597 @default.
• W2005282952 hasConcept C2779429289 @default.
• W2005282952 hasConcept C2780401358 @default.
• W2005282952 hasConcept C2781107101 @default.
• W2005282952 hasConcept C2781413609 @default.
• W2005282952 hasConcept C2909962599 @default.
• W2005282952 hasConcept C3019892230 @default.
• W2005282952 hasConcept C55493867 @default.
• W2005282952 hasConcept C71924100 @default.
• W2005282952 hasConcept C86803240 @default.

• next